Yang (Amy) Xu is a Principal Scientist and Research Investigator in Translational Bioinformatics at Bristol Myers Squibb. Previously, Yang held the position of Postdoctoral Fellow in Translational Science and Oncology Bioinformatics at AstraZeneca. Yang also contributed as a Research Associate at both the University of Minnesota and Hennepin Healthcare, as well as serving as a Graduate Student at the University of Massachusetts Medical School. Yang earned a Doctor of Philosophy (Ph.D.) in Systems Biology from UMass Chan Medical School, following academic training at Harvard University from September 2017 to September 2019.
December, 2021 - present
September, 2019